Integral Diagnostics Ltd
ASX:IDX
Integral Diagnostics Ltd
ASX:IDX
Price:
2.36
AUD
0.43%
Market Closed
Market Cap:
AU$880.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Integral Diagnostics Ltd
ASX:IDX
|
AU |
|
H
|
Hyungkuk F&B Co Ltd
KOSDAQ:189980
|
KR |
|
C
|
Cognizant Technology Solutions Corp
BMV:CTSH
|
US |
|
Muthoot Finance Ltd
NSE:MUTHOOTFIN
|
IN |
|
M
|
Microsoft Corp
SGO:MSFT
|
US |
|
Flag Ship Acquisition Corp
NASDAQ:FSHP
|
US |
|
U
|
Uniphar PLC
ISEQ:UPR
|
IE |
|
Accelerant Holdings
NYSE:ARX
|
KY |
|
Uniserve Communications Corp
XTSX:USS
|
CA |
|
S
|
Shougang Fushan Resources Group Ltd
HKEX:639
|
HK |
Multiples-Based Value
The Multiples-Based Value of one
IDX
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 2.36 AUD,
Integral Diagnostics Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IDX Multiples-Based Value
LOCKED
Multiples Across Competitors
IDX Competitors Multiples
Integral Diagnostics Ltd Competitors
Integral Diagnostics Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Integral Diagnostics Ltd
ASX:IDX
|
878.7m AUD | 1.1 | 62.6 | 20.1 | 20.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
91.3B USD | 0.2 | 52.1 | 13.5 | 13.5 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
66.4B EUR | 0.3 | 13.1 | 7.7 | 9.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
70.3B USD | 0.3 | 11.8 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.8B EUR | 1.1 | 19.6 | 9.3 | 13.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.9B EUR | 1.2 | 23.4 | 9 | 16.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD | 1.6 | 25.6 | 12.3 | 17.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 2 | 22.1 | 11.9 | 16.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.5 | 11 | 5.3 | 9.8 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.1B USD | 12.3 | -29 | -31.7 | -28.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.5B USD | 0.8 | 13.8 | 7.2 | 9.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
